The Middle East and Africa Cath Lab Services Market is anticipated to grow at more than 6.77% CAGR from 2026 to 2031.
The Middle East and Africa Cath Lab Services market is undergoing rapid transformation, fueled by a rising cardiovascular disease burden and significant government investments in healthcare infrastructure. National governments are actively expanding access to cardiac care by funding new catheterization labs, with Uganda opening its fifth lab in 2025, Kenya launching a new unit at Moi Teaching and Referral Hospital, and Rwanda partnering with Siemens Healthineers to deploy labs across 19 public hospitals. Regulation across the region is fragmented but crucial for market access. In Saudi Arabia, the Saudi Food and Drug Authority enforces the Medical Device Marketing Authorization, requiring all Class III cath lab devices to undergo rigorous clinical evaluation, with a four-tier risk classification system aligned with the Global Harmonization Task Force framework. In the UAE, the Ministry of Health and Prevention oversees approval, and many regulatory tasks have recently transitioned to the newly established Emirates Drug Establishment in 2026. South Africa's SAHPRA requires ISO 13485 certification and comprehensive clinical evaluation evidence for medical device licenses. Regional harmonization is advancing; in October 2025, the GCC Standardization Organization signed a technical cooperation agreement with the European Committee for Standardization to align medical device standards. A landmark development in April 2026 was Medtronic's completion of the $585 million acquisition of CathWorks, significantly bolstering its portfolio of diagnostic tools that are essential for cath labs. In the region, FUJIFILM Middle East launched its Interventional Cardiology Business Line in February 2026 through a strategic alliance with Innvolution Healthcare, unveiling the initiative at the WHX Dubai 2026 event to distribute cath lab solutions across MEA. According to the research report, "Middle East and Africa Cath Lab Services Market Outlook, 2031," published by Bonafide Research, the Middle East and Africa Cath Lab Services Market is anticipated to grow at more than 6.77% CAGR from 2026 to 2031. In Egypt, Philips is conducting a joint feasibility study with the Ministry of Health to localize the manufacturing of CT scan machines, a move that could signal deeper local production of key cath lab imaging components. Numerous technological advancements, new product launches, and significant medical events are shaping the MEA Cath Lab Services landscape. WHX Dubai 2026, held in February 2026, was a landmark event that showcased the latest innovations in interventional cardiology. At this expo, FUJIFILM Middle East officially launched its Interventional Cardiology Business Line, and United Imaging Healthcare unveiled its full-modality portfolio, including advanced angiography systems. In a major move toward procedural efficiency, American Hospital Dubai became the first in the region to acquire a Hybrid Cath Lab from Varian Medical Systems, integrating interventional cardiology, radiology, and surgical capabilities into a single platform. Simultaneously, Badr Al Samaa Royal Hospital in Oman signed a MoU with FUJIFILM to introduce the country's first private-sector AI-powered Cath Lab, integrating Intracoronary Optical Coherence Tomography and Intravascular Lithotripsy. In May 2026, the National Cardiology Center in Mauritania announced the successful completion of its first PFA procedure using Medtronic's PulseSelect system. This follows the OPTION-EMEA post-market clinical study, which is gathering real-world data on the FARAPULSE PFA System and WATCHMAN FLX devices.
to Download this information in a PDF
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download SampleMarket Drivers • Rising Burden of Cardiovascular Diseases: One of the key drivers of the Middle East and Africa Cath Lab Services Market is the increasing prevalence of cardiovascular diseases across the region. Rapid urbanization, sedentary lifestyles, unhealthy dietary habits, smoking, diabetes, and obesity have significantly contributed to a growing number of heart-related conditions. In many Middle Eastern countries, high rates of diabetes and hypertension are particularly strong risk factors, while in parts of Africa, limited preventive care leads to late-stage diagnosis of cardiac diseases. As a result, there is a rising demand for advanced diagnostic and interventional procedures such as angiography, angioplasty, and stent implantation. • Expanding Healthcare Infrastructure: another major driver is the steady improvement in healthcare infrastructure and increasing government investments in modern medical facilities. Countries such as the UAE, Saudi Arabia, and South Africa are heavily investing in advanced hospitals, specialty cardiac centers, and diagnostic technologies as part of broader healthcare modernization programs. These investments aim to improve access to high-quality care and reduce dependence on overseas treatment. The expansion of private healthcare providers and medical tourism initiatives in the Middle East further supports the establishment of state-of-the-art cath labs. Market Challenges • Limited Infrastructure in Low-Income Regions: A major challenge in the Middle East and Africa Cath Lab Services Market is the significant disparity in healthcare infrastructure between developed and underdeveloped areas. While countries in the Gulf region have advanced hospitals equipped with modern cath labs, many parts of Africa still face shortages of basic healthcare facilities, trained professionals, and diagnostic equipment. This uneven distribution results in limited access to life-saving cardiac procedures for a large portion of the population. • Limited Affordability of Advanced Cardiac Procedures: Another important challenge is the high cost associated with establishing and operating cath lab facilities, along with the limited affordability of advanced cardiac procedures for many patients. The equipment required for cath labs is expensive and ongoing operational costs, including maintenance, consumables, and skilled staff, add further financial burden. In several countries within the region, healthcare financing systems and insurance coverage are not sufficiently developed, leading to high out-of-pocket expenses for patients. Market Trends • Increasing Adoption of Advanced Cardiac Imaging: A growing trend in the Middle East and Africa Cath Lab Services Market is the adoption of advanced imaging technologies and digital healthcare solutions. Hospitals are increasingly integrating high-resolution imaging systems, intravascular ultrasound, AI-assisted diagnostic tools, and real-time monitoring systems to improve the accuracy and safety of cardiac procedures. These technologies help physicians make better clinical decisions and enhance procedural outcomes. • Growth of Private Healthcare: another significant trend is the rapid expansion of private healthcare providers and the development of medical tourism, particularly in Gulf countries such as the UAE and Saudi Arabia. Private hospitals are investing heavily in advanced cath lab infrastructure to attract both domestic and international patients seeking high-quality cardiac care. Competitive healthcare offerings, shorter waiting times, and internationally accredited facilities are making the region an attractive destination for cardiac treatments.
| By Service Type | Diagnostic Services | |
| Therapeutic Services | ||
| By End User | Hospitals | |
| Specialty Cardiac Clinics | ||
| Ambulatory Surgical Centers | ||
| Others (Clinics, Mobile Labs) | ||
| By Appication | Cardiovascular / Cardiac | |
| Peripheral Vascular | ||
| Brain & Spine / Neuro | ||
| MEA | United Arab Emirates | |
| Saudi Arabia | ||
| South Africa | ||
The leading growth of therapeutic services in the Middle East and Africa cath lab services market is driven by the rising burden of cardiovascular diseases combined with increasing adoption of minimally invasive interventional procedures as the primary mode of cardiac treatment across expanding healthcare systems. The expansion of therapeutic services in the Middle East and Africa cath lab landscape is strongly influenced by the region’s growing prevalence of cardiovascular conditions, which are being accelerated by lifestyle changes, urbanization, dietary transitions, and rising rates of diabetes, hypertension, and obesity. These risk factors have significantly increased the incidence of coronary artery disease and acute cardiac events, creating a strong need for timely and effective treatment approaches that go beyond diagnosis. As a result, catheter-based therapeutic procedures have become the central focus of cath lab utilization, particularly percutaneous coronary interventions, balloon angioplasty, and stent implantation, which are widely used to restore blood flow and manage life-threatening cardiac conditions. Healthcare systems across the Middle East, especially in Gulf Cooperation Council countries, have been rapidly investing in advanced hospital infrastructure, including state-of-the-art cardiac centers equipped with modern cath lab technologies, enabling physicians to perform increasingly complex interventions with higher precision and safety. In parallel, many countries across Africa are gradually strengthening their healthcare capacity, with international collaborations, public-private partnerships, and donor-supported initiatives contributing to the establishment and upgrading of cardiac care facilities. The growing availability of trained interventional cardiologists has also played a crucial role in expanding the use of therapeutic procedures, as medical training programs and global knowledge exchange have improved clinical expertise in minimally invasive cardiac interventions. Ambulatory surgical centers are the fastest-growing end user segment in the Middle East and Africa cath lab services market due to the increasing shift toward cost-effective, minimally invasive cardiac procedures that reduce hospital burden and enable same-day treatment in outpatient settings. The rapid growth of ambulatory surgical centers in the Middle East and Africa cath lab services landscape is closely connected to the region’s ongoing efforts to improve healthcare efficiency, expand access to specialized care, and reduce pressure on large tertiary hospitals. In many Middle Eastern countries, healthcare systems are experiencing rising demand for cardiovascular services due to increasing prevalence of lifestyle-related risk factors such as obesity, diabetes, hypertension, and sedentary behavior, which contribute to a growing number of patients requiring diagnostic and interventional cardiac procedures. At the same time, hospital infrastructure, particularly in rapidly developing urban areas, often faces capacity constraints, making it necessary to shift appropriate low- to moderate-risk procedures to outpatient settings such as ambulatory surgical centers. These centers are increasingly being equipped with modern cath lab facilities capable of performing procedures like diagnostic coronary angiography and selected percutaneous coronary interventions safely without overnight hospitalization. In addition, governments in the Gulf region are actively promoting healthcare privatization and diversification, encouraging investment in specialized outpatient facilities that improve service efficiency and patient throughput. In parts of Africa, the development of ambulatory centers is supported by international healthcare partnerships and private sector participation aimed at improving access to essential cardiac care in urban centers. Cardiovascular or cardiac applications lead the Middle East and Africa cath lab services market because of the high and increasing prevalence of coronary artery disease and related heart conditions that require frequent diagnostic and interventional catheter-based treatments. The dominance of cardiovascular and cardiac applications in the Middle East and Africa cath lab services market is primarily driven by the significant and growing burden of heart diseases across the region, which continues to be one of the leading causes of mortality and long-term health complications. Lifestyle changes such as increased consumption of high-calorie diets, reduced physical activity, rising obesity rates, and a high prevalence of diabetes and hypertension have contributed to a substantial rise in coronary artery disease and acute cardiac events. These conditions often require immediate and precise medical intervention, which is most effectively delivered through catheterization laboratories. Cath labs play a central role in both diagnosing and treating cardiovascular conditions through procedures such as coronary angiography and percutaneous coronary intervention, which are widely used to restore blood flow in blocked arteries and prevent severe cardiac damage. In the Middle East, particularly in Gulf countries, healthcare systems are highly focused on expanding advanced cardiac care infrastructure, with significant investments in specialized hospitals and cardiac centers equipped with modern cath lab technologies. This has improved access to interventional procedures and increased procedure volumes. In Africa, although healthcare infrastructure varies widely, urban hospitals and private healthcare facilities are gradually expanding their capacity to perform essential cardiac interventions, supported by international partnerships and healthcare development programs.
to Download this information in a PDF
Saudi Arabia is the largest market in the Middle East and Africa cath lab services sector due to its highly developed healthcare infrastructure, strong government investment in advanced cardiac care facilities, and widespread availability of interventional cardiology services across major hospitals. The leading position of Saudi Arabia in the Middle East and Africa cath lab services market is primarily the result of its sustained and strategic investment in healthcare modernization, particularly in the field of cardiovascular care, which is considered a national health priority. The country has one of the most advanced hospital networks in the region, with a high concentration of tertiary care and specialized cardiac centers located in major cities such as Riyadh, Jeddah, and Dammam. These hospitals are equipped with state-of-the-art catheterization laboratories that support a wide range of diagnostic and therapeutic procedures, including coronary angiography, percutaneous coronary interventions, structural heart interventions, and electrophysiology procedures. The strong presence of both public healthcare institutions and rapidly expanding private hospital groups has significantly increased access to advanced cardiac services for the population. Saudi Arabia also faces a high burden of cardiovascular diseases, largely influenced by lifestyle-related risk factors such as obesity, diabetes, hypertension, and sedentary behavior, which are prevalent across a large segment of the population. This has created sustained demand for both emergency and elective cardiac interventions performed in cath labs. The government’s healthcare transformation initiatives, aligned with long-term national development programs, have prioritized the expansion of specialized care capacity and the adoption of cutting-edge medical technologies, further strengthening cath lab infrastructure.
to Download this information in a PDF

We are friendly and approachable, give us a call.